M3V — MeVis Medical Solutions AG Cashflow Statement
0.000.00%
Last trade - 00:00- €44.41m
- €37.88m
- €16.06m
- 93
- 49
- 62
- 82
Annual cashflow statement for MeVis Medical Solutions AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | GAS | GAS | GAS | GAS | GAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4.55 | 7.79 | 4.92 | 4.56 | 3.17 |
| Depreciation | |||||
| Non-Cash Items | 0.218 | -0.678 | -0.667 | -1.7 | -0.727 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.24 | -2.35 | 1.51 | 0.148 | 1.29 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 9.13 | 4.86 | 5.85 | 3.15 | 3.88 |
| Capital Expenditures | -0.051 | -0.133 | -0.08 | -0.302 | -0.14 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.162 | 0.192 | 1.07 | 1.21 | 1.09 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.112 | 0.059 | 0.99 | 0.907 | 0.945 |
| Financing Cash Flow Items | -0 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Cash from Financing Activities | -5.7 | -4.55 | -7.79 | -4.92 | -4.56 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.67 | 1.7 | -1.58 | -1.22 | -0.004 |